Xuelian Chen
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Surgery
- Topics
- HER2/EGFR in Cancer Research (12 papers)Advanced Breast Cancer Therapies (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xuelian Chen
32 papers receiving 769 citations
Peers
Comparison fields: 5 of 72
- Oncology 462
- Molecular Biology 218
- Pulmonary and Respiratory Medicine 209
- Cancer Research 163
- Surgery 149
Countries citing papers authored by Xuelian Chen
This map shows the geographic impact of Xuelian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuelian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuelian Chen more than expected).
Fields of papers citing papers by Xuelian Chen
This network shows the impact of papers produced by Xuelian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuelian Chen. The network helps show where Xuelian Chen may publish in the future.
Co-authorship network of co-authors of Xuelian Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Xuelian Chen. A scholar is included among the top collaborators of Xuelian Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuelian Chen. Xuelian Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 5 | |
| 8 | 11 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 12 | |
| 12 | 9 | |
| 13 | 5 | |
| 14 | 149 | |
| 15 | 14 | |
| 16 | 122 | |
| 17 | 5 | |
| 18 | 8 | |
| 19 | 3 | |
| 20 | 10 |
About Xuelian Chen
Xuelian Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 36 papers that have together received 779 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), Advanced Breast Cancer Therapies (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (462 citations), Cancer Research (163 citations) and Pulmonary and Respiratory Medicine (209 citations). Xuelian Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Binghe Xu, Hongnan Mo, Bo Lan, Jing Huang, Dawei Wu, Qing Yang, Dong Qu, Xingyuan Wang, Manjiao Zhuang and Long Qian. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.